Latest News

By the end of last week, markets rebounded from their lows, with the S&P 500 and Canadian TSX indexes posting positive returns after a challenging March. Despite ongoing uncertainties and elevated oil prices, there is cautious optimism about potential de-escalation and improved oil flows. In this context, penny stocks—often representing smaller or newer companies—remain an intriguing area for investors seeking growth opportunities at lower price points. While the term may seem outdated, these...

Select Water Solutions (WTTR) has drawn fresh attention after recent share price moves, with the stock last closing at $15.36. Investors are weighing this level against the company’s financial profile and water-focused energy services business. See our latest analysis for Select Water Solutions. Recent trading has added to a strong run, with a 10.34% 1 month share price return and a 36.65% 3 month share price return contributing to a 38.50% year to date share price gain. The 1 year total...

Eramet (ENXTPA:ERA) is back in focus after reports that its largest shareholder may exit. A legal clash with Chilean miner ENAMI also threatens to delay a major lithium project tied to a planned €3b investment. See our latest analysis for ERAMET. At a share price of €49.68, ERAMET has seen a 31.24% 3 month share price decline and an 11.21% 1 month share price decline, while the 1 year total shareholder return is 15.02%. This suggests that momentum has faded as investors weigh ownership...

Alumis Inc. recently reported Phase 3 ONWARD1 and ONWARD2 data showing its oral TYK2 inhibitor envudeucitinib produced high rates of robust, durable skin clearance and quality-of-life improvements in adults with moderate-to-severe plaque psoriasis through Week 24, with a generally well-tolerated safety profile. An interesting aspect for investors is envudeucitinib’s maximal 24-hour TYK2 inhibition without fasting requirements, aiming to balance efficacy, convenience, and selective immune...

Praxis Precision Medicines (PRAX) is back on investors’ radar after it reported positive topline results from its EMBRAVE Part A trial of elsunersen in pediatric SCN2A developmental and epileptic encephalopathy. See our latest analysis for Praxis Precision Medicines. The positive elsunersen readout comes on top of recent progress with relutrigine, which is now under priority FDA review for certain developmental and epileptic encephalopathies. This has helped support an 8.78% 90-day share...

NMI Holdings recently announced a US$250.00 million share repurchase program running through December 2027, following a period of consistent earnings outperformance and solid operating results that have strengthened investor confidence. This combination of disciplined capital returns and robust fundamental execution underscores management’s focus on enhancing shareholder value while reinforcing the company’s position in the private mortgage insurance market. With this sizeable buyback plan...

Solstice Advanced Materials (SOLS) recently drew attention after Hudson Technologies signed a licensing agreement to reclaim and resell Solstice branded R-448A and R-449A refrigerants in the United States and Canada. See our latest analysis for Solstice Advanced Materials. Since early in the year, interest around Solstice Advanced Materials has lined up with stronger share price momentum, with a 90 day share price return of 59.95% and a year to date share price return of 69.14% alongside...

If you are wondering whether Aramark at around US$43.31 still offers value or is starting to look stretched, the next sections will walk through what the current price may be implying. The stock has seen returns of 3.4% over the last 7 days, 7.4% over 30 days, 18.4% year to date, 29.0% over 1 year, 77.4% over 3 years, and 61.4% over 5 years. This naturally raises questions about how much optimism is already in the price. Recent attention on Aramark has centered on how the business is...

In recent days, Wall Street analysts have become more positive on Enova International, revising earnings per share estimates higher and assigning the company a favorable Zacks Rank #2. This broad-based earnings optimism, highlighted by strong agreement among analysts, reflects increasing confidence in Enova’s business outlook and earnings resilience. With analysts revising earnings estimates upward, we’ll now examine how this growing confidence could reshape Enova International’s existing...

The United States market has experienced a notable upswing, climbing 3.0% in the last week and rising 26% over the past year, with earnings projected to grow by 16% annually. In this context of robust market performance, identifying stocks that may be trading below their estimated intrinsic value could offer investors potential opportunities for growth and value appreciation.

The United States market has shown robust performance, with a 3.0% rise over the last week and a 26% increase over the past year, while earnings are anticipated to grow by 16% annually in the coming years. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often reflect strong confidence from those closest to the business.

The United States market has experienced a robust climb, rising 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In light of these conditions, identifying stocks with strong financials and growth potential is crucial for investors looking to capitalize on market opportunities. Although penny stocks may seem like an outdated term, they continue to represent smaller or newer companies that can offer significant value; this article highlights...

The United States market has shown robust performance, climbing 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors looking to capitalize on emerging trends.

The United States market has shown robust performance, with a 3.0% increase over the last week and a substantial 26% rise in the past year, as earnings are projected to grow by 16% annually. In this thriving environment, identifying dividend stocks that offer both reliable income and potential for growth can be an effective strategy for investors looking to capitalize on these favorable conditions.

Norse Wind vessel puts DEME Group (ENXTBR:DEME) in focus DEME Group (ENXTBR:DEME) has drawn fresh investor attention after christening the Norse Wind, a new offshore wind installation vessel equipped with a 3,200-tonne crane and a hybrid power system. The ship is built to install larger next generation turbines and operate in harsher offshore conditions. Its hybrid setup targets more than 70% emission reductions. Norse Wind already carries long term contracts for major European offshore wind...

Snowline Gold Corp. has reported full-year 2025 results, recording a net loss of C$54.18 million versus C$31.23 million a year earlier, with basic loss per share from continuing operations rising to C$0.33 from C$0.20. The widening loss highlights the company’s increased spending or reduced income over the year, which may influence how investors assess its progress and risk profile. Next, we examine how Snowline Gold's wider full-year loss helps shape the company’s investment narrative and...

Why UFP Technologies is on investors’ radar today Recent share price moves in UFP Technologies (UFPT), including a 6.2% gain over the past day and negative returns over the month and past 3 months, have drawn fresh attention to the medical packaging specialist. See our latest analysis for UFP Technologies. That 6.25% 1 day share price return has come after a weaker patch, with a 30 day share price return of 6.75% and a 90 day share price return of 21.51%. The 1 year total shareholder return...

On April 6, 2026, Barclays analyst Terry Ma reaffirmed an "Overweight" rating on SLM Corporation while adopting a more cautious outlook on the company. This shift in analyst sentiment, combined with upcoming first-quarter 2026 results announced for April 23, 2026, is prompting investors to reassess SLM's prospects. Now we’ll consider how Barclays’ more cautious stance, despite retaining a positive rating, may influence SLM’s existing investment narrative. The best AI stocks today may lie...

Recent updates around WillScot Holdings (WSC) focus on a 13% year over year EBITDA decline, a 13% drop in units on rent, and write offs affecting roughly 15% of its rental fleet. See our latest analysis for WillScot Holdings. Recent price action reflects those operational concerns, with the share price at US$18.84 after a 3.23% 1 day gain and 6.92% 7 day share price return. However, a 27.78% 1 year total shareholder return loss and 53.81% 3 year total shareholder return loss point to weaker...

Production guidance reaffirmed after Cyclone Narelle disruption Ramelius Resources (ASX:RMS) reaffirmed its 2025–26 production targets after Cyclone Narelle disrupted operations, stating that output remains on track for the midpoint of guidance, supported by Dalgaranga performance and ongoing share buybacks. See our latest analysis for Ramelius Resources. The reaffirmed guidance comes as Ramelius Resources trades at A$4.07, with a 7 day share price return of 10.60% contrasting with modestly...

Eni (BIT:ENI) reports a major natural gas and condensate discovery at the Denise W-1 well in Egypt's offshore Temsah Concession. The find is estimated at around 2 trillion cubic feet of gas and 130 million barrels of condensates. The discovery sits close to existing infrastructure, creating potential for fast-track development and commercialization. For you as an investor, this discovery adds a fresh element to the Eni story beyond earlier headlines on valuation, biofuels financing, and...

Delta Air Lines (DAL) opened 2026 with Q1 revenue of US$15.9b and a basic EPS loss of US$0.44, as net income swung to a loss of US$289m against a strong Q4 2025, when the company posted revenue of US$16.0b and basic EPS of US$1.88. Over the past year, revenue on a trailing basis has held near US$65.2b while basic EPS moved to US$6.89, and the trailing net profit margin of 6.9% sits above last year’s 5.9%. This provides a clearer view of how margins are trending through the current soft...

If you are wondering whether Grand Canyon Education at around US$171.76 is offering fair value or hiding a margin of safety, the next sections will help you frame that question clearly. The stock has returned 0.2% over the last 7 days, 6.6% over the last 30 days, 3.9% year to date, 0.9% over 1 year, 43.9% over 3 years and 51.6% over 5 years, which gives useful context before comparing the current price to underlying value. Recent coverage has focused on Grand Canyon Education as a US listed...

Satellogic (NasdaqCM:SATL) announced a $50 million at-the-market follow-on equity offering. The company plans to issue new shares over time into the open market, rather than in a single, fixed-price transaction. The offering size is material relative to a small-cap issuer and may affect capital structure and future funding flexibility. Satellogic focuses on high-frequency Earth observation, using a constellation of satellites to provide data and imagery to commercial and government...